Swedish
Investerare
Aktieägare
EQT logo
Om
Medarbetare
Hållbarhet
Investeringar
Media
Current portfolio
XyloCor Therapeutics
US biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease
Sektor
Healthcare
Land
United States
Fond
LSP 6
Entry
2018
Web
xylocor.com
Sektor
Healthcare
Land
United States
Fond
LSP 6
Entry
2018
Web
xylocor.com
Investments
EQT logo